Amrize (NYSE:AMRZ) Price Target Raised to $70.00 at JPMorgan Chase & Co.

Amrize (NYSE:AMRZ) had its price target increased by research analysts at JPMorgan Chase & Co. from $60.00 to $70.00 in a research report issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 13.64% from the stock’s previous close.

Other equities research analysts also recently issued reports about the company. Vertical Research assumed coverage on Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 target price on the stock. Berenberg Bank set a $70.00 price target on shares of Amrize in a research note on Thursday, February 19th. Royal Bank Of Canada increased their price objective on shares of Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a research report on Thursday, February 19th. Bank of America set a $58.00 target price on shares of Amrize in a report on Monday, January 12th. Finally, Truist Financial upped their target price on shares of Amrize from $60.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $64.14.

Amrize Trading Down 1.8%

NYSE:AMRZ traded down $1.13 during midday trading on Thursday, reaching $61.60. 4,375,599 shares of the stock traded hands, compared to its average volume of 3,527,711. The stock has a market capitalization of $34.07 billion and a P/E ratio of 25.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The company has a fifty day moving average of $57.47 and a 200 day moving average of $53.31. Amrize has a 12 month low of $44.12 and a 12 month high of $65.94.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. The firm’s revenue for the quarter was down .4% on a year-over-year basis.

Insider Buying and Selling at Amrize

In other news, CFO Ian A. Johnston purchased 1,200 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were purchased at an average cost of $63.92 per share, for a total transaction of $76,704.00. Following the purchase, the chief financial officer directly owned 18,544 shares in the company, valued at approximately $1,185,332.48. This represents a 6.92% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Institutional Trading of Amrize

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp bought a new stake in shares of Amrize during the 2nd quarter valued at $38,803,000. Metis Global Partners LLC purchased a new stake in Amrize in the 2nd quarter worth $635,000. Aviva PLC bought a new stake in Amrize during the second quarter valued at about $29,836,000. Credit Industriel ET Commercial bought a new stake in Amrize during the second quarter valued at about $109,000. Finally, Rathbones Group PLC purchased a new position in shares of Amrize in the second quarter valued at about $257,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.